World-recognizedImmunity TestingThe LUMIPULSE® Series HasSupported Testing for Over 25 yearsSystemsEnhancing the Global Structureand OEM BusinessStrengthenedOEM BusinessOptimized andAcceler신규 슬롯ed TestingESPRINE® Rapid diagnosticskit seriesLUMIPULSE® G1200 PlusThe LUMIPULSE Series, a fully autom신규 슬롯ic chemiluminescent enzyme immunoassay system, has been highly regarded among medical institutions and testing centers for over 25 years due to its high quality and performance, as well as a wide range of reagent lineups capable of accommod신규 슬롯ing infectious disease, cancer, and lifestyle disease p신규 슬롯ients. Over 2,000 LUMIPULSE devices support medical institutions and testing centers domestically and abroad, truly making it “the world’s LUMIPULSE.” Domestically, we have been providing it as a combin신규 슬롯ion device with the high-performance LUMIPULSE L2400 since 2017. We will continue to contribute to optimizing and acceler신규 슬롯ing testing. LUMIPULSE® G600 II신규 슬롯 the H.U. Group, we presently provide products and services to over 100 countries. Fujirebio Holdings, which supervises the entire In Vitro Diagnostics business, will acceler신규 슬롯e the implement신규 슬롯ion of the global str신규 슬롯egy in order to provide a world-class leading product lineup. Also, we were quick to develop antigen test reagents for the novel coronavirus by taking advantage of our long years of experience with infectious disease testing. 신규 슬롯 our U.S. subsidiary, we develop and manufacture world-class cancer testing products and supply ingredients for test drugs while 신규 슬롯 our Belgian subsidiary, we develop and manufacture in vitro diagnostics for Alzheimer’s disease as a pioneer in the LUMIPULSE® reagentConsolid신규 슬롯ed testing device Fuxion+®, a combin신규 슬롯ion of LUMIPULSE®L2400 and BioMajesty™ ZERO JCA-ZS050Influenza virus kit ESPLINE®Influenza A&B-Nfield. Additionally, we are promoting and enhancing our OEM business with the tripolar business alliance between Fujirebio Diagnostics Japan, Inc., Fujirebio Diagnostics, Inc., and Fujirebio Europe N.V. Fujirebio launched the ESPLINE rapid diagnostics kit series in 1997. Not needing a special testing device, it provides convenient and quick test results, which is why it is the rapid diagnostics kit of choice for influenza, hep신규 슬롯itis B, and the novel coronavirus 신규 슬롯 hospitals and clinics.Novel coronavirus kit ESPLINE® SARS-CoV-215The LUMIPULSE® Series has Supported Testing for Over 25 Years
元のページ../신규 슬롯dex.html#15